Phase IV Evaluation of the Adrenal Suppression Potential and PKPD of Halobetasol Propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.